FDA cites Cipla India plant after U.S. recall of asthma drug – FiercePharma Manufacturing

FDA cites Cipla India plant after U.S. recall of asthma drug
FiercePharma Manufacturing
In May, India's Cipla voluntarily pulled a lot of its levalbuterol from the U.S. market after the asthma inhalation drug failed a test for a degradant. Shortly after, FDA inspectors visited the plant in Indore where Cipla made the product and came away

and more »

View full post on asthma – Google News

Cipla rises 4% on asthma drug launch, Kotak says buy – Moneycontrol.com


Moneycontrol.com

Cipla rises 4% on asthma drug launch, Kotak says buy
Moneycontrol.com
Shares of Cipla surged 4 percent intraday on Thursday on launch of asthma treatment medicine. In partnership with Sandoz, the drug company has launched Pulmicort Respules 1mg /ml version which is used for long-term treatment of asthma and prevention …
Cipla surges after its partner Sandoz received USFDA nod for a key drugBusiness Standard

all 4 news articles »

View full post on asthma – Google News

Cipla Ltd launches copy of GSK’s top asthma drug in Germany, Sweden – Economic Times


Economic Times

Cipla Ltd launches copy of GSK's top asthma drug in Germany, Sweden
Economic Times
MUMBAI: Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be marketed under

View full post on asthma – Google News

India’s Cipla launches copy of GSK’s top asthma drug in Germany, Sweden – Reuters


Economic Times

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
Reuters
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will
Cipla targets US with asthma, HIV drugsMoneyweb.co.za

all 22 news articles »

View full post on asthma – Google News

India’s Cipla Launches Copy Of GSK’s Top Asthma Drug In Germany, Sweden – Business Insider


Economic Times

India's Cipla Launches Copy Of GSK's Top Asthma Drug In Germany, Sweden
Business Insider
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will
Cipla launches Serroflo in Germany and Sweden with affordable high quality pharmabiz.com

all 6 news articles »

View full post on asthma – Google News